at Investor's Business Daily (Jan 20, 2015)
Reasons for selling a stock can be many, but there's only one reason for insiders to buy : they...
Reasons for selling a stock can be many, but there's only one reason for insiders to buy : they expect the stock to go higher. Looking for a leg-up on where to put some money to work? Here's what a couple insiders have been doing this week: On Monday, Valeant Pharmaceuticals' (VRX) Director, Laurence E. Paul, bought 5k shares of VRX, while on the same day Rosetta Resources (ROSE) Executive VP, CFO & Treasurer John E. Hagale bought 6k worth of of his own company as well.
From other sites
at Investor's Business Daily (Jan 16, 2015)
at Investor's Business Daily (Jan 15, 2015)
at Zacks.com (Jan 15, 2015)
UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noiseat Benzinga.com (Jan 14, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs